- Home
- PGEN vs BKE Comparison
PGEN vs BKE Comparison
Compare PGEN & BKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PGEN | BKE |
|---|---|---|
| Founded | 1998 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2013 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PGEN | BKE |
|---|---|---|
| Price | $6.86 | $42.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $8.33 | ★ $53.00 |
| AVG Volume (30 Days) | ★ 6.2M | 377.7K |
| Earning Date | 05-13-2026 | 05-22-2026 |
| Dividend Yield | N/A | ★ 7.96% |
| EPS Growth | N/A | ★ 6.43 |
| EPS | 0.03 | ★ 0.92 |
| Revenue | $230,981,000.00 | ★ $1,297,835,000.00 |
| Revenue This Year | $1,115.92 | $5.10 |
| Revenue Next Year | $81.04 | $4.99 |
| P/E Ratio | $231.00 | ★ $46.30 |
| Revenue Growth | N/A | ★ 6.58 |
| 52 Week Low | $2.99 | $40.73 |
| 52 Week High | $7.72 | $61.69 |
Technical Indicators
Market Signals| Indicator | PGEN | BKE |
|---|---|---|
| Relative Strength Index (RSI) | 55.27 | 41.62 |
| Support Level | $3.96 | $41.37 |
| Resistance Level | $7.32 | $43.82 |
| Average True Range (ATR) | 0.39 | 1.15 |
| MACD | -0.07 | -0.20 |
| Stochastic Oscillator | 51.38 | 10.13 |
Price Performance
Historical ComparisonAbout PGEN Precigen Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.